The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 15, 2022

Filed:

Feb. 22, 2019
Applicant:

Kindeva Drug Delivery L.p., Saint Paul, MN (US);

Inventors:

Stephen W. Stein, Lino Lakes, MN (US);

David W. Schultz, Pine Springs, MN (US);

John K. Simons, Davie, FL (US);

William F. Hansen, Riverfalls, WI (US);

Assignee:

Kindeva Drug Delivery L.P., St. Paul, MN (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 9/00 (2006.01); A61K 47/10 (2017.01); A61K 47/32 (2006.01); A61K 45/06 (2006.01); A61K 9/16 (2006.01); A61M 15/00 (2006.01); A61K 9/46 (2006.01); A61K 31/137 (2006.01); A61K 31/167 (2006.01); A61K 31/58 (2006.01); A61K 47/06 (2006.01); B65B 31/00 (2006.01);
U.S. Cl.
CPC ...
A61K 9/008 (2013.01); A61K 9/0007 (2013.01); A61K 9/1688 (2013.01); A61K 31/137 (2013.01); A61K 31/167 (2013.01); A61K 31/58 (2013.01); A61K 45/06 (2013.01); A61K 47/06 (2013.01); A61K 47/10 (2013.01); A61K 47/32 (2013.01); A61M 15/009 (2013.01); B65B 31/003 (2013.01);
Abstract

The present disclosure provides a method of preparing a pharmaceutical composition. The method includes transferring a predetermined quantity of an excipient mixture from a second vessel to a first vessel. The excipient mixture transferred from the second vessel includes a liquid-state second quantity of a hydrofluoroalkane propellant and a first solubilized excipient comprising a low-molecular weight poly(ethylene oxide) polymer. The method further includes contacting at least one pharmaceutically-active compound with the excipient mixture under conditions that facilitate forming an intermixture comprising the propellant, the polymer, and the compound. Before transferring the excipient mixture, the first vessel contains a vapor-phase first quantity of the hydrofluoroalkane propellant and an effective amount of the at least one pharmaceutically-active compound.


Find Patent Forward Citations

Loading…